연구 보고서
publishing_series72_drug_cancer.pdf
개요
현재 우리나라 인구 4명중 1명이 암으로 사망하는 등 암은 국민건강에 커다란 위협 요인으로 대두
되고 있으며 고령화 및 환경변화 등으로 암사망과 암발생은 더욱 심화될 것으로 전망되고 있음.
또한 세계적인 암 발생 및 암사망은 지속적인 증가추세에 있어 암정복을 위한 예방ㆍ진단ㆍ치료 기술개발은
인류공통의 시급한 과제임.
목차
1. 기술개요
가. 정의 및 특성 ·································································································· 1
나. 기술개발 필요성 ···························································································· 4
1) 전반적 현황 ·································································································· 4
2) 국내 현황 ······································································································ 6
2. 서지분석
가. 특허 및 논문분석을 위한 기술분류 및 검색 범위 ······························ 8
1) 기술분류 및 검색범위 ················································································ 8
2) 특허 검색키워드 및 검색조건 ·································································· 8
3) 논문 검색키워드 및 검색조건 ·································································· 9
나. 특허분석 결과 ······························································································ 9
1) 특허로 살펴본 한국인 3대 암(위암, 폐암, 간암)의 세계동향 ········· 9
2) 특허로 살펴본 한국인 3대 암(위암, 폐암, 간암)의 국내동향 ······· 14
다. 논문분석 결과 ···························································································· 17
1) 논문으로 살펴본 한국인 3대 암(위암, 폐암, 간암)의 세계동향 ··· 17
2) 논문으로 살펴본 한국인 3대 암(위암, 폐암, 간암)의 국내동향 ··· 20
라. 시장성 분석․관련 산업동향 ······································································· 23
1) 해외시장 동향 및 전망 ··········································································· 23
2) 국내시장 동향 ··························································································· 30
3. 기술개발 동향
가. 세계동향 ······································································································ 32
1) 주요국의 정책동향 ················································································· 32
2) 기술개발 동향 ························································································· 43
3) 주요기업 및 동향 ··················································································· 48
나. 국내동향 ········································································································ 53
1) 국가 암 관리 정책 ················································································· 53
2) 정부 투자 현황 및 주요 연구개발 사업 ············································· 56
3) 국내 주요 연구자 및 연구성과 ··························································· 58
4. 국내외 기술수준 비교
가. 기술수준비교 ······························································································ 63
나. SWOT 분석 ·································································································· 64
5. 기대효과 및 시사점
가. 기대효과 ······································································································ 65
나. 시사점 및 대응방안 ·················································································· 65
6. 참고문헌
별첨 1. 한국인 3대 암(위암, 간암, 폐암) 관련 특허분석
별첨 2. 한국인 3대 암(위암, 간암, 폐암) 관련 논문분석
지식